中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2015年
5期
529-532
,共4页
牛姣姣%王露%刘晓%潘韫丹%张重%覃罡%王锷
牛姣姣%王露%劉曉%潘韞丹%張重%覃罡%王鍔
우교교%왕로%류효%반운단%장중%담강%왕악
右美托咪啶%心肺转流术%心脏瓣膜假体植入%血流动力学%肾
右美託咪啶%心肺轉流術%心髒瓣膜假體植入%血流動力學%腎
우미탁미정%심폐전류술%심장판막가체식입%혈류동역학%신
Dexmedetomidine%Cardiopulmonary bypass%Heart valve prosthesis implantation%Hemodynamics%Kidney
目的:探讨右美托咪定对CPB心脏瓣膜置换术患者肾血流动力学的影响。方法择期拟行CPB心脏瓣膜置换术患者30例,年龄18~60岁,体重42~68 kg,ASA分级Ⅱ?Ⅳ级。采用随机数字表法分为2组( n=15):对照组( C组)和右美托咪定组( D组)。 D组麻醉诱导后经10 min静脉输注右美托咪定负荷量0.5μg∕kg,随后以0.5~1.0μg·kg-1·h-1的速率静脉输注至手术结束。于麻醉诱导后即刻(右美托咪定给药前)、CPB 30 min、CPB结束后30 min时采用经食管超声心动图测量CO和肾血流动力学指标:肾动脉内径、肾动脉平均血流速度、肾血流量、肾动脉搏动指数和阻力指数。于麻醉诱导后即刻、CPB结束后2、12和24 h时取桡动脉血样,采用ELISA法测定血浆中性粒细胞白明胶酶相关脂质运载蛋白和胱抑素C的浓度。结果与C组比较,D组CPB 30 min和CPB结束后30 min时肾血流量增加,CPB结束后各时点血浆中性粒细胞白明胶酶相关脂质运载蛋白浓度降低( P<0.05),其余肾血流动力学指标、CO和血浆胱抑素C浓度差异无统计学意义( P>0.05)。结论右美托咪定可增加CPB心脏瓣膜置换术患者肾血流量,产生肾保护作用。
目的:探討右美託咪定對CPB心髒瓣膜置換術患者腎血流動力學的影響。方法擇期擬行CPB心髒瓣膜置換術患者30例,年齡18~60歲,體重42~68 kg,ASA分級Ⅱ?Ⅳ級。採用隨機數字錶法分為2組( n=15):對照組( C組)和右美託咪定組( D組)。 D組痳醉誘導後經10 min靜脈輸註右美託咪定負荷量0.5μg∕kg,隨後以0.5~1.0μg·kg-1·h-1的速率靜脈輸註至手術結束。于痳醉誘導後即刻(右美託咪定給藥前)、CPB 30 min、CPB結束後30 min時採用經食管超聲心動圖測量CO和腎血流動力學指標:腎動脈內徑、腎動脈平均血流速度、腎血流量、腎動脈搏動指數和阻力指數。于痳醉誘導後即刻、CPB結束後2、12和24 h時取橈動脈血樣,採用ELISA法測定血漿中性粒細胞白明膠酶相關脂質運載蛋白和胱抑素C的濃度。結果與C組比較,D組CPB 30 min和CPB結束後30 min時腎血流量增加,CPB結束後各時點血漿中性粒細胞白明膠酶相關脂質運載蛋白濃度降低( P<0.05),其餘腎血流動力學指標、CO和血漿胱抑素C濃度差異無統計學意義( P>0.05)。結論右美託咪定可增加CPB心髒瓣膜置換術患者腎血流量,產生腎保護作用。
목적:탐토우미탁미정대CPB심장판막치환술환자신혈류동역학적영향。방법택기의행CPB심장판막치환술환자30례,년령18~60세,체중42~68 kg,ASA분급Ⅱ?Ⅳ급。채용수궤수자표법분위2조( n=15):대조조( C조)화우미탁미정조( D조)。 D조마취유도후경10 min정맥수주우미탁미정부하량0.5μg∕kg,수후이0.5~1.0μg·kg-1·h-1적속솔정맥수주지수술결속。우마취유도후즉각(우미탁미정급약전)、CPB 30 min、CPB결속후30 min시채용경식관초성심동도측량CO화신혈류동역학지표:신동맥내경、신동맥평균혈류속도、신혈류량、신동맥박동지수화조력지수。우마취유도후즉각、CPB결속후2、12화24 h시취뇨동맥혈양,채용ELISA법측정혈장중성립세포백명효매상관지질운재단백화광억소C적농도。결과여C조비교,D조CPB 30 min화CPB결속후30 min시신혈류량증가,CPB결속후각시점혈장중성립세포백명효매상관지질운재단백농도강저( P<0.05),기여신혈류동역학지표、CO화혈장광억소C농도차이무통계학의의( P>0.05)。결론우미탁미정가증가CPB심장판막치환술환자신혈류량,산생신보호작용。
Objective To investigate the effects of dexmedetomidine on renal hemodynamics in patients undergoing cardiac valve replacement with cardiopulmonary bypass ( CPB) . Methods Thirty ASA physical status Ⅱ?Ⅳ patients of both sexes, aged 18-60 yr, weighing 42-68 kg, scheduled for elective cardiac valve replacement with CPB, were randomized into two groups ( n=15 each) using a random number table: control group ( group C ) and dexmedetomidine group ( group D ) . In group D, after induction of anesthesia, dexmedetomidine was given with a 0. 5μg∕kg loading bolus over 10 min, followed by an infusion of 0.5-1.0 μg·kg-1 ·h-1 throughout the surgery. Immediately after induction of anesthesia (before administration of dexmedetomidine), at 30 min of CPB, and at 30 min after the end of CPB, cardiac output and indexes of renal hemodynamics including the internal diameter of left renal artery, mean renal blood flow velocity, renal blood flow volume, and renal artery pulsatility index and resistance index were measured by transesophageal echocardiography. Immediately after induction of anesthesia, and at 2, 12 and 24 h after the end of CPB, arterial blood samples were collected for measurement of the concentrations of neutrophil gelatinase lipocalin?2 and cystatin C in plasma by enzyme?linked immunosorbent assay. Results Compared with group C, the renal blood flow volume was significantly increased at 30 min of CPB and 30 min after the end of CPB, the concentrations of neutrophil gelatinase lipocalin?2 in plasma were decreased at each time point after CPB, and no significant differences were found in the other indexes of renal hemodynamics, cardiac output and concentrations of cystatin C in plasma in group D. Conclusion Dexmedetomidine can increase renal blood flow volume and thus provides renoprotection in patients undergoing cardiac valve replacement with CPB.